ZA986064B - Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and their use. - Google Patents

Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and their use.

Info

Publication number
ZA986064B
ZA986064B ZA9806064A ZA986064A ZA986064B ZA 986064 B ZA986064 B ZA 986064B ZA 9806064 A ZA9806064 A ZA 9806064A ZA 986064 A ZA986064 A ZA 986064A ZA 986064 B ZA986064 B ZA 986064B
Authority
ZA
South Africa
Prior art keywords
ancrod
mixtures
derivatives
monoclonal antibodies
antibody fragments
Prior art date
Application number
ZA9806064A
Other languages
English (en)
Inventor
Thomas Subkowski
Wilfried Hornberger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA986064B publication Critical patent/ZA986064B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA9806064A 1997-07-10 1998-07-09 Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and their use. ZA986064B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19729544A DE19729544A1 (de) 1997-07-10 1997-07-10 Ancrod spezifische monoklonale Antikörper, Antikörperfragmente, deren Mischung oder Derivate und deren Verwendung

Publications (1)

Publication Number Publication Date
ZA986064B true ZA986064B (en) 2000-01-10

Family

ID=7835268

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9806064A ZA986064B (en) 1997-07-10 1998-07-09 Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and their use.

Country Status (14)

Country Link
US (1) US6365155B1 (cs)
EP (1) EP1000087A2 (cs)
JP (1) JP2002511880A (cs)
KR (1) KR20010021649A (cs)
CN (1) CN1262690A (cs)
AU (1) AU748841B2 (cs)
BR (1) BR9810574A (cs)
CA (1) CA2295218A1 (cs)
CZ (1) CZ297216B6 (cs)
DE (1) DE19729544A1 (cs)
IL (1) IL133224A0 (cs)
NO (1) NO20000079L (cs)
WO (1) WO1999002564A2 (cs)
ZA (1) ZA986064B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR079944A1 (es) * 2010-01-20 2012-02-29 Boehringer Ingelheim Int Anticuerpo neutralizante de la actividad de un anticoagulante

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3841736A1 (de) * 1988-12-10 1990-07-05 Basf Ag Ancrod-proteine, ihre herstellung und verwendung
CA2015127A1 (en) * 1989-04-26 1990-10-26 John G. Gray, Jr. Novel dna sequences which encode ancrod-like polypeptides and compositions comprising the expression products thereof
ATE138478T1 (de) * 1992-02-17 1996-06-15 Akzo Nobel Nv Kalibrator und verwendung davon in einer immuntest
US5523292A (en) * 1992-10-14 1996-06-04 Schwartz; Robert Method of preventing restenosis following coronary angioplasty

Also Published As

Publication number Publication date
AU748841B2 (en) 2002-06-13
JP2002511880A (ja) 2002-04-16
BR9810574A (pt) 2000-09-19
AU8540698A (en) 1999-02-08
IL133224A0 (en) 2001-03-19
US6365155B1 (en) 2002-04-02
WO1999002564A3 (de) 1999-04-01
EP1000087A2 (de) 2000-05-17
KR20010021649A (ko) 2001-03-15
NO20000079L (no) 2000-03-07
CN1262690A (zh) 2000-08-09
DE19729544A1 (de) 1999-01-14
NO20000079D0 (no) 2000-01-07
CZ297216B6 (cs) 2006-10-11
WO1999002564A2 (de) 1999-01-21
CZ200057A3 (cs) 2000-05-17
CA2295218A1 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
TR199501614A2 (tr) Anti-alfa integrin monoklonal antikor.
IL128406A0 (en) Monoclonal antibodies
AU1332099A (en) Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
EP1071458A4 (en) HUMANIZED ANTIBODIES AND CORRESPONDING USES THEREOF
AU1704099A (en) Monoclonal human natural antibodies
IS8950A (is) Einklóna mótefni gegn CTLA-4 úr manni.
IL147517A0 (en) Monoclonal antibodies and immunoassay utilizing the same
EP0634019A4 (en) IMMUNOASSAYS USING GENE ANTI-HAPTEN ANTIBODIES AND MATERIALS TO BE USED.
EP0805161A4 (en) PROTEIN BINDING (1-3) -BETA-D-GLUCANE, PROTEIN RECOGNIZING ANTIBODIES AND USE OF PROTEIN AND ANTIBODY
HUP0103152A3 (en) Monoclonal antibodies directed against the g3bp protein, and uses
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU7072998A (en) Immunoassays using anti-allotypic monoclonal antibodies
AU2547995A (en) Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
EP0977590A4 (en) HUMAN MONOCLONAL ANTIBODIES
ZA9510195B (en) Monoclonal antibody fragments having immunosuppressant activity
AU2596397A (en) Monoclonal antibody that detects apoptotic antigen
AU5137698A (en) Novel dna, novel protein, and novel antibody
AU3257399A (en) Monoclonal antibodies esm-1 protein specific, and use of said antibodies for detecting esm-1 protein
HUP0202270A3 (en) Antitumor antibodies, proteins, and uses thereof
GB9718911D0 (en) Monoclonal antibodies
ZA986064B (en) Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and their use.
ZA941645B (en) Antibodies specifically reactive against human prostate specific antigen.
AU1809695A (en) Tumor associated monoclonal antibody 123av16
EP0654532A4 (en) ANTIMUCOGLYCOPROTEIN MONOCLONAL ANTIBODIES.
HUP0003029A3 (en) Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same